Akros U.S. High Dividend 20 Index

Chief Operating Officer James Holland will retire effective September 4, 2026, and will be succeeded by Ken Grubb. Low importance is estimated as management succession is planned and expected to be smooth scheduled.

Third quarter 2026 earnings release is scheduled.

Target's Q2 2026 earnings release is scheduled for August 19, 2026, with analysts forecasting EPS of approximately $2.21 to $2.26. Medium importance is assigned as earnings typically drive 5-10% price volatility scheduled.

Canadian Natural Resources is scheduled to release its 2026 Second Quarter Results on August 6, 2026, followed by a conference call; significant price impact from earnings and outlook scheduled

Manulife Financial is scheduled to release its Q2 2026 financial results after market close on August 5, 2026, with analysts forecasting EPS around $0.80. Impact is estimated as Low (>=1%) as the market typically reacts to the actual surprise rather than the schedule, scheduled.

On August 3, 2026, the second-quarter 2026 earnings release is scheduled after market close. Price impact is estimated at >=5%, justifying a medium importance scheduled.

Q2 2026 earnings release scheduled for July 31, 2026, which is estimated to have a high market impact exceeding 10% scheduled.

Q2 2026 earnings release and conference call scheduled for July 31, 2026. Market impact is estimated to be low as it is a routine financial update scheduled.

As earnings releases typically result in a 5-10% price impact, the Q2 2026 earnings release and conference call on July 30, 2026, is scheduled.

Exelon will announce its second quarter 2026 financial results before the market opens on July 30, 2026, with a conference call at 10:00 AM ET, scheduled. The price impact is estimated to be 1-5% given the stock's low volatility.

Mondelez International will release its second quarter 2026 financial results on Tuesday, July 28, 2026. Estimated 5% impact due to historical earnings volatility, scheduled.

Verizon is scheduled to report its Q2 2026 earnings results before the market opens on July 24, 2026. Analysts forecast EPS of approximately $1.26-$1.27, scheduled.

A general meeting of shareholders is scheduled for July 23, 2026, to vote on a proposed $2.0 billion share repurchase program supported by Glass Lewis but opposed by ISS; this is estimated to have a high market impact exceeding 10% scheduled.

Blackstone is scheduled to announce its Q2 2026 financial results on July 23, 2026, before the market opens. Analysts forecast earnings of approximately $1.33 per share and revenue of around $3.37 billion. High importance is estimated based on historical volatility during earnings periods. scheduled

Q2 2026 earnings release for Honeywell Technologies following the Aerospace spin-off; analysts forecast EPS of $1.79-$1.81; high volatility expected for the first post-restructuring report scheduled.

Q2 2026 earnings release with an EPS of approximately $0.97 analysts forecasted is scheduled. A 5% price impact is estimated based on historical earnings surprises.

Kinder Morgan is scheduled to release its Q2 2026 earnings results after market close on July 22, 2026, with analysts forecasting EPS of $0.31 on revenue of $4.20B. High importance is estimated as earnings typically drive significant price volatility forecasted.

AT&T is scheduled to release its second-quarter 2026 financial results before the market opens on July 22, 2026, with analysts forecasting EPS of approximately $0.59 and revenue around $31.8 billion. This event is scheduled.

Completion of the acquisition of Johnson Matthey's Catalyst Technologies business for £1.325 billion on 2026-07-17; medium price impact estimated from business expansion scheduled.

Reported Q2 2026 earnings with diluted EPS of $1.23, beating analyst expectations of $1.08. Total revenue was $5.31 billion, a 5.5% increase year-over-year, driven by a 72% surge in investment banking and trading revenue. Importance is Medium due to the 5.5% revenue growth expected.

Verizon announced a restructuring plan on July 17, 2026, which includes cutting approximately 3,000 jobs and selling 270 retail stores to independent franchisees.

On July 17, 2026, Oppenheimer maintained its "Outperform" rating on Blackstone but lowered its price target to $139 from $156. estimated

On July 17, 2026, Jefferies analysts are expected to downgrade ONEOK to Hold and lower the price target to $95. Price impact is estimated at >=1%, justifying a low importance forecasted.

Filed applications with federal and state regulators on July 16, 2026, seeking approval for the proposed merger with NextEra Energy.

Completed the acquisition of SPR Therapeutics on July 16, 2026, a medical technology company specializing in peripheral nerve stimulation (PNS) therapies for pain management. This acquisition expands Medtronic's pain therapy portfolio.

U.S. Bancorp reported Q2 2026 financial results, with diluted EPS of $1.35 beating analyst estimates. The company posted record quarterly revenue of $7.71 billion and raised its full-year 2026 revenue growth guidance.

On July 16, 2026, JPMorgan Chase & Co. reduced its price target for Blackstone to $132 from $136, while maintaining a "Neutral" rating. estimated

On July 15, 2026, ONEOK is scheduled to declare a $1.07 quarterly dividend, unchanged from the previous quarter, payable on August 14, 2026, to shareholders of record on August 3, 2026. Price impact is estimated at >=1%, justifying a low importance scheduled.

The U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for mezigdomide on July 13, 2026, for patients with relapsed or refractory multiple myeloma. The target action date is May 13, 2027.